期刊文献+

慢性阻塞性肺疾病,可防可治 被引量:4

Chronic Obstructive Pulmonary Disease is Preventable and Curable
暂未订购
导出
摘要 慢性阻塞性肺疾病(COPD)的发病与吸烟密切相关,发病率呈逐年上升趋势。近年来的多项研究结果表明,COPD是一种可以治疗的疾病,关键在于早期干预和正确使用治疗药物,其研究进展也不断改变着临床医生对COPD的认识。由复旦大学附属中山医院呼吸内科主任白春学教授主持的COPD专题,从炎症反应在COPD发病机制中的作用,免疫调节在COPD发病机制中的地位和意义,化痰药物和抗胆碱药物在COPD治疗中的作用等方面详细介绍了COPD研究的最新进展和发展前景。 Many studies in the recent years showed that,Chronic obstructive pulmonary disease(COPD)is a treatable disease, and the key is earlyintervention and proper use of medicines andthe studying progress has been changing theclinician's understanding of the COPD.COPDcolumn hosted by Professor Bai Chun-xuefrom Zhongshan Hospital of Fudan Universitydescribes the latest progress and developmentprospect of COPD study in detail from the role ofinflammatory reaction in COPD pathogenesis,the position and signif icance of immune regulationin the pathogenesis of COPD, the roles of Phlegmdrugs and anticholinergic drugs in the treatment ofCOPD and other aspects.
作者 白春学
出处 《中国处方药》 2010年第5期28-29,共2页 Journal of China Prescription Drug
  • 相关文献

同被引文献40

  • 1慢性阻塞性肺疾病诊疗规范(2011年版)[J].中国医学前沿杂志(电子版),2012,4(1):69-76. 被引量:264
  • 2赵双平,郭曲练,艾宇航,王瑞珂,王锷,贺民.沐舒坦对吸入性肺损伤大鼠的肺保护作用[J].中国危重病急救医学,2005,17(6):364-366. 被引量:30
  • 3芮铭安,王曹锋,陈谊,杜勤.家庭氧疗对COPD患者心理情绪及生活质量的影响[J].实用老年医学,2005,19(3):135-137. 被引量:8
  • 4慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8237
  • 5Hattotuwa KL, Gizycki M J, Ansari TW, et al. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study[J]. Am J Respir Crit Care Med, 2002, 165(7): 1592-1596.
  • 6Calverley P, Pauwels R, Vestboet J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease:a randomised controlled trial[J]. Lancet, 2003, 361(5):449-456.
  • 7NanniniL J Jr, Flores DM. Bronchodilator effect of zafirlukast in subjects with chronic obstructive pulmonary disease [J]. Pulm Phamacol Ther, 2003, 16 (7) :307-311.
  • 8Tug T, Karatas F, Terzi SM. Antioxidant vitamins (A, C and E ) and malondialdehyde levels in acute exacerbation and stable periods of patients with chronic obstructive pulmonary disease[J]. Clin Invest Mel,2004, 27(6):123-128.
  • 9Compton CH, Gubb J, Nieman R, et al. Cilomilast, a selective Phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease a randomised, dose-ranging study[J]. Lancet, 2001, 358(2):265-270.
  • 10Burke JR, Payoff MA, Gregor KR, et al. BM S2345541 is a highly selective inhibitor of I kappa B kinase that binds at all allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice [J]. J Biol Chem, 2003,278(6) :1450-1456.

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部